
Acorda Therapeutics ACOR
Country |
|
IPO year |
2006 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
1.24 M |
Market Cap[1] |
$ 820 K |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Merck & Co.
MRK
|
$ 146.9 | -2.29 % | $ 368 B | NYSE,SPB | ||
|
Fusion Pharmaceuticals
FUSN
|
- | - | $ 1.41 B | Nasdaq Global Select Market | ||
|
Gritstone Oncology
GRTS
|
- | 0.42 % | $ 213 M | Nasdaq Global Select Market | ||
|
Harpoon Therapeutics
HARP
|
- | - | $ 763 M | Nasdaq Global Select Market | ||
|
HOOKIPA Pharma
HOOK
|
- | -6.92 % | $ 79.4 M | Nasdaq Global Select Market | ||
|
Guardion Health Sciences
GHSI
|
- | -0.31 % | $ 3.64 M | Nasdaq Capital Market | ||
|
Opiant Pharmaceuticals
OPNT
|
- | - | $ 109 M | Nasdaq Global Select Market | ||
|
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | ||
|
Otonomy
OTIC
|
- | -1.96 % | $ 4.68 M | Nasdaq Global Select Market | ||
|
Aridis Pharmaceuticals
ARDS
|
- | 17.91 % | $ 11.1 M | Nasdaq Capital Market | ||
|
Seagen
SGEN
|
- | - | $ 42.2 B | Nasdaq Global Select Market,SPB | ||
|
Baudax Bio
BXRX
|
- | 0.59 % | $ 63 K | Nasdaq Capital Market | ||
|
ChemoCentryx
CCXI
|
- | - | $ 3.74 B | Nasdaq Global Select Market,SPB | ||
|
Avid Bioservices
CDMO
|
- | - | $ 789 M | Nasdaq Capital Market | ||
|
Zosano Pharma Corporation
ZSAN
|
- | 7.23 % | $ 2.72 M | Nasdaq Global Select Market | ||
|
Oncternal Therapeutics
ONCT
|
- | -24.12 % | $ 1.56 M | Nasdaq Capital Market | ||
|
Iterum Therapeutics
ITRM
|
- | - | $ 591 K | Nasdaq Global Select Market | ||
|
Spectrum Pharmaceuticals
SPPI
|
- | - | $ 189 M | Nasdaq Global Select Market | ||
|
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | ||
|
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | ||
|
Concert Pharmaceuticals
CNCE
|
- | - | $ 401 M | Nasdaq Global Market | ||
|
ImmunoGen
IMGN
|
- | - | $ 7.92 B | Nasdaq Global Select Market | ||
|
Vascular Biogenics Ltd.
VBLT
|
- | -8.77 % | $ 12.4 M | Nasdaq Global Select Market | ||
|
Histogen
HSTO
|
- | 31.6 % | $ 2.12 M | Nasdaq Global Select Market | ||
|
Berkeley Lights
BLI
|
- | -7.31 % | $ 87 M | Nasdaq Global Select Market | ||
|
Cidara Therapeutics
CDTX
|
- | - | $ 1.41 B | Nasdaq Global Market | ||
|
Clovis Oncology
CLVS
|
- | -7.23 % | $ 13 M | Nasdaq Global Select Market | ||
|
Kaleido Biosciences
KLDO
|
- | -3.69 % | $ 12.4 M | Nasdaq Global Select Market | ||
|
VBI Vaccines
VBIV
|
- | -50.87 % | $ 1.09 M | Nasdaq Capital Market | ||
|
CTI BioPharma Corp.
CTIC
|
- | - | $ 1.2 B | Nasdaq Capital Market | ||
|
Decibel Therapeutics
DBTX
|
- | - | $ 123 M | Nasdaq Global Select Market | ||
|
NuCana plc
NCNA
|
$ 0.93 | -8.43 % | $ 10.4 B | Nasdaq Global Select Market | ||
|
PhaseBio Pharmaceuticals
PHAS
|
- | 7.4 % | $ 6.29 M | Nasdaq Global Market | ||
|
Provention Bio
PRVB
|
- | - | $ 2.37 B | Nasdaq Global Select Market | ||
|
IVERIC bio
ISEE
|
- | - | $ 5.51 B | Nasdaq Global Select Market | ||
|
Reata Pharmaceuticals
RETA
|
- | - | $ 6.29 B | Nasdaq Global Market,SPB | ||
|
ObsEva SA
OBSV
|
- | -15.52 % | $ 10.5 M | Nasdaq Global Select Market | ||
|
PolarityTE
PTE
|
- | -0.82 % | $ 1.78 M | Nasdaq Capital Market | ||
|
Kronos Bio
KRON
|
- | 1.49 % | $ 50.8 M | Nasdaq Global Select Market | ||
|
Landos Biopharma
LABP
|
- | 0.58 % | $ 144 M | Nasdaq Global Market | ||
|
Myovant Sciences Ltd.
MYOV
|
- | -0.04 % | $ 2.62 B | NYSE | ||
|
Poseida Therapeutics
PSTX
|
- | - | $ 857 M | Nasdaq Global Select Market | ||
|
Checkmate Pharmaceuticals
CMPI
|
- | - | $ 231 M | Nasdaq Global Market | ||
|
Trevena
TRVN
|
- | -46.58 % | $ 31.8 M | Nasdaq Capital Market | ||
|
Immunovant
IMVT
|
$ 28.43 | -4.92 % | $ 5.19 B | Nasdaq Global Select Market | ||
|
Virpax Pharmaceuticals
VRPX
|
- | -45.12 % | $ 2.85 M | Nasdaq Global Select Market | ||
|
Oncorus
ONCR
|
- | -8.54 % | $ 3.19 M | Nasdaq Global Market | ||
|
Y-mAbs Therapeutics
YMAB
|
- | - | $ 382 M | Nasdaq Global Select Market,SPB | ||
|
Navidea Biopharmaceuticals
NAVB
|
- | -2.99 % | $ 2.47 M | NYSE American | ||
|
InMed Pharmaceuticals
INM
|
$ 13.1 | -26.38 % | $ 54.5 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.